Geode Capital Management, LLC Electro Core, Inc. Transaction History

Geode Capital Management, LLC

$1.21 Trillion
Q3 2024

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 13, 2023	SELL	$0.21 - $5.63 $262 - $7,026	-1,248 Reduced 0.2%	629,078 $161,000
Q2 2022 Aug 12, 2022	BUY	$0.27 - $0.61 $3,761 - $8,497	13,930 Added 2.26%	630,326 $321,000
Q1 2022 May 13, 2022	BUY	$0.5 - $0.88 $1,490 - $2,622	2,980 Added 0.49%	616,396 $360,000
Q4 2021 Feb 11, 2022	BUY	$0.58 - $1.09 $53,937 - $101,365	92,996 Added 17.87%	613,416 $357,000
Q3 2021 Nov 12, 2021	SELL	$0.93 - $1.18 $20,334 - $25,800	-21,865 Reduced 4.03%	520,420 $588,000
Q2 2021 Aug 13, 2021	BUY	$1.19 - $2.06 $71,109 - $123,097	59,756 Added 12.38%	542,285 $645,000
Q1 2021 May 12, 2021	BUY	$1.62 - $3.05 $230,177 - $433,359	142,085 Added 41.74%	482,529 $994,000
Q4 2020 Feb 12, 2021	BUY	$1.44 - $1.98 $66,980 - $92,097	46,514 Added 15.82%	340,444 $531,000
Q3 2020 Nov 13, 2020	BUY	$0.8 - $2.33 $22,360 - $65,123	27,950 Added 10.51%	293,930 $508,000
Q2 2020 Aug 13, 2020	BUY	$0.75 - $1.29 $46,157 - $79,390	61,543 Added 30.1%	265,980 $218,000
Q1 2020 May 14, 2020	BUY	$0.33 - $1.62 $14,143 - $69,431	42,859 Added 26.53%	204,437 $194,000
Q4 2019 Feb 13, 2020	BUY	$1.23 - $2.67 $43,051 - $93,452	35,001 Added 27.65%	161,578 $256,000
Q3 2019 Nov 12, 2019	BUY	$1.25 - $5.0 $210 - $840	168 Added 0.13%	126,577 $277,000
Q2 2019 Aug 14, 2019	BUY	$1.65 - $6.72 $28,969 - $117,983	17,557 Added 16.13%	126,409 $252,000
Q1 2019 May 14, 2019	BUY	$4.84 - $9.07 $305,984 - $573,405	63,220 Added 138.54%	108,852 $761,000
Q4 2018 Feb 13, 2019	BUY	$4.21 - $14.28 $52,953 - $179,613	12,578 Added 38.05%	45,632 $285,000
Q3 2018 Nov 13, 2018	BUY	$13.02 - $17.54 $430,363 - $579,767	33,054 New	33,054 $462,000

Others Institutions Holding ECOR

# of Institutions

Shares Held

143K

Call Options Held

Put Options Held

View Full List

About electroCore, Inc.

Ticker ECOR
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 71,176,896
Market Cap $1.12B
Description
electroCore, Inc., a commercial stage medical device company, engages in the development and commercialization of a range of non-invasive vagus nerve stimulation (nVNS) therapies. The company is developing gammaCore, a prescription-only nVNS therapy for the acute treatment of pain associated with migraine and episodic cluster headache in adults....

More about ECOR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Geode Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Geode Capital Management, LLC with notifications on news.

Account